Nanoparticles for cancer therapy: current progress and challenges
S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …
Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
Y Yao, Y Zhou, L Liu, Y Xu, Q Chen, Y Wang… - Frontiers in molecular …, 2020 - frontiersin.org
Nanotechnology has been extensively studied and exploited for cancer treatment as
nanoparticles can play a significant role as a drug delivery system. Compared to …
nanoparticles can play a significant role as a drug delivery system. Compared to …
Recent advances in nanomaterials-based targeted drug delivery for preclinical cancer diagnosis and therapeutics
Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …
Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐and radioresistances
P Kola, PKB Nagesh, PK Roy, K Deepak… - Wiley …, 2023 - Wiley Online Library
The alarming increase in the number of breast cancer patients worldwide and the increasing
death rate indicate that the traditional and current medicines are insufficient to fight against …
death rate indicate that the traditional and current medicines are insufficient to fight against …
Drug release profiles of mitomycin c encapsulated quantum dots–chitosan nanocarrier system for the possible treatment of non-muscle invasive bladder cancer
Nanotechnology-based drug delivery systems are an emerging technology for the targeted
delivery of chemotherapeutic agents in cancer therapy with low/no toxicity to the non-cancer …
delivery of chemotherapeutic agents in cancer therapy with low/no toxicity to the non-cancer …
Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers
S Ashique, A Garg, A Hussain, A Farid… - Cancer …, 2023 - Wiley Online Library
Background Cancer treatment is still a global health challenge. Nowadays, chemotherapy is
widely applied for treating cancer and reducing its burden. However, its application might be …
widely applied for treating cancer and reducing its burden. However, its application might be …
[PDF][PDF] Kajal; Salvi, P.; Singh, SK; Gautam, V
H Tiwari, N Rai - … in Nanomaterials-Based Targeted Drug Delivery …, 2023 - researchgate.net
Nano-oncology is a branch of biomedical research and engineering that focuses on using
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …
nanotechnology in cancer diagnosis and treatment. Nanomaterials are extensively …
p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection
Cancer cells acquire immunoediting ability to evade immune surveillance and thus escape
eradication. It is widely known that mutant proteins encoded from tumor suppressor TP53 …
eradication. It is widely known that mutant proteins encoded from tumor suppressor TP53 …
Effect of 1α,25(OH)2 Vitamin D3 in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1
S Cataldi, C Arcuri, A Lazzarini, I Nakashidze… - Cancers, 2020 - mdpi.com
Simple Summary The active form of vitamin D3 slows proliferation and stimulates
differentiation of glioblastoma cells with mutated p53 by acting via neutral sphingomyelinase …
differentiation of glioblastoma cells with mutated p53 by acting via neutral sphingomyelinase …
[HTML][HTML] Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin …
Glucosylceramide synthase (GCS) is a key enzyme catalyzing ceramide glycosylation to
generate glucosylceramide (GlcCer), which in turn serves as the precursor for cells to …
generate glucosylceramide (GlcCer), which in turn serves as the precursor for cells to …